Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Niu Technologies
138.2% sales growth and 20.55% return on equity
Niu Technologies designs, manufactures, and sells smart electric-scooters in the People's Republic of China.
Niu Technologies's sales growth this year is expected to be 22.9% and 75.5% for next year.
Year-on-year quarterly revenue growth grew by 36.7%, now sitting on N/A for the twelve trailing months.
Niu Technologies's sales growth for the next quarter is 138.2%. The company's growth estimates for the current quarter and the next is a negative 38.5% and 250%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.55%.
Volatility
Niu Technologies's last day, last week, and last month's average volatility was a positive 2.57%, a positive 0.33%, and a negative 0.13%, respectively.
Niu Technologies's last day, last week, and last month's high and low average amplitude percentage was 7.30%, 5.12%, and 5.82%, respectively.
Niu Technologies's Stock Yearly Top and Bottom Value
Niu Technologies's stock is valued at $28.79 at 13:22 EST, way below its 52-week high of $37.44 and way higher than its 52-week low of $6.08.
Niu Technologies's Moving Average
Niu Technologies's worth is under its 50-day moving average of $29.97 and way above its 200-day moving average of $24.08.2. Accenture plc.
12.3% sales growth and 31.34% return on equity
Accenture plc provides consulting, technology, and outsourcing services worldwide.
Accenture plc.'s sales growth this year is expected to be 8% and 7.2% for next year.
Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 44.73B for the twelve trailing months.
Accenture plc.'s sales growth for the next quarter is 12.3%. The company's growth estimates for the ongoing quarter and the next is a negative 1% and 13.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.34%.
Volatility
Accenture plc.'s last day, last week, and last month's average volatility was 1.09%, 0.23%, and 0.14%, respectively.
Accenture plc.'s last day, last week, and last month's high and low average amplitude percentage was 2.58%, 1.85%, and 1.70%, respectively.
Accenture plc.'s Stock Yearly Top and Bottom Value
Accenture plc.'s stock is valued at $263.30 at 13:22 EST, under its 52-week high of $271.18 and way higher than its 52-week low of $137.15.
Accenture plc.'s Moving Average
Accenture plc.'s worth is above its 50-day moving average of $252.43 and way higher than its 200-day moving average of $233.67.3. Eli Lilly and Company
13.7% sales growth and 131.77% return on equity
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide.
Eli Lilly and Company's sales growth this year is expected to be 9.3% and 12.3% for next year.
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 23.21B for the twelve trailing months.
News about Eli Lilly and Company today
According to today's article on Business Insider, "Boehringer Ingelheim and Eli Lilly and Company (LLY) announced the FDA has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin) for adults with heart failure with reduced ejection fraction. "
According to today's article on Business Insider, "Shares of drug maker Eli Lilly and Company (LLY) are climbing more than 11% Monday morning on the news of FDA accepting supplemental New Drug Application for its type 2 diabetes treatment Jardiance."
Eli Lilly and Company's sales growth for the next quarter is 13.7%. The company's growth estimates for the current quarter and the next is 35.8% and 13.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 131.77%.
Volatility
Eli Lilly and Company's last day, last week, and last month's average volatility was a positive 0.35%, a negative 0.29%, and a positive 0.53%, respectively.
Eli Lilly and Company's last day, last week, and last month's high and low average amplitude percentage was 1.35%, 2.66%, and 2.34%, respectively.
Eli Lilly and Company's Stock Yearly Top and Bottom Value
Eli Lilly and Company's stock is valued at $166.41 at 13:22 EST, under its 52-week high of $173.90 and way higher than its 52-week low of $117.06.
Eli Lilly and Company's Moving Average
Eli Lilly and Company's worth is above its 50-day moving average of $158.00 and higher than its 200-day moving average of $152.89.4. Atmos Energy Corporation
12.1% sales growth and 9.59% return on equity
Atmos Energy Corporation, together with its subsidiaries, engages in the regulated natural gas distribution, and pipeline and storage businesses in the United States.
Atmos Energy Corporation's sales growth this year is expected to be 19.3% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 7%, now sitting on 2.82B for the twelve trailing months.
Atmos Energy Corporation's sales growth is a negative 0% for the present quarter and 12.1% for the next. The company's growth estimates for the current quarter and the next is 6.8% and 5.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.59%.
Volatility
Atmos Energy Corporation's last day, last week, and last month's average volatility was a positive 1.19%, a positive 0.12%, and a negative 0.18%, respectively.
Atmos Energy Corporation's last day, last week, and last month's high and low average amplitude percentage was 1.75%, 2.30%, and 2.10%, respectively.
Atmos Energy Corporation's Stock Yearly Top and Bottom Value
Atmos Energy Corporation's stock is valued at $89.77 at 13:22 EST, way below its 52-week high of $121.08 and way above its 52-week low of $77.92.
Atmos Energy Corporation's Moving Average
Atmos Energy Corporation's worth is below its 50-day moving average of $96.13 and below its 200-day moving average of $98.05.5. AbbVie
50.4% sales growth and 209.12% return on equity
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.
AbbVie's sales growth this year is anticipated to be 37.3% and 18% for next year.
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
AbbVie's sales growth for the next quarter is 50.4%. The company's growth estimates for the present quarter and the next is 29.4% and 18.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 209.12%.
Volatility
AbbVie's last day, last week, and last month's average volatility was a positive 0.52%, a positive 0.02%, and a negative 0.02%, respectively.
AbbVie's last day, last week, and last month's high and low average amplitude percentage was 1.67%, 2.32%, and 2.00%, respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $109.35 at 13:22 EST, under its 52-week high of $109.43 and way higher than its 52-week low of $62.55.
AbbVie's Moving Average
AbbVie's value is higher than its 50-day moving average of $105.09 and way higher than its 200-day moving average of $95.58.6. Big Lots, Inc.
6.9% sales growth and 61.92% return on equity
Big Lots, Inc., through its subsidiaries, operates as a retailer in the United States.
Big Lots, Inc.'s sales growth this year is expected to be 16.9% and a negative 7.2% for next year.
Year-on-year quarterly revenue growth grew by 18%, now sitting on 6.07B for the twelve trailing months.
Big Lots, Inc.'s sales growth for the next quarter is 6.9%. The company's growth estimates for the present quarter and the next is 25.1% and 4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 61.92%.
Volatility
Big Lots, Inc.'s last day, last week, and last month's average volatility was a negative 0.57%, a positive 0.70%, and a positive 0.01%, respectively.
Big Lots, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 4.32%, 4.32%, and 3.77%, respectively.
Big Lots, Inc.'s Stock Yearly Top and Bottom Value
Big Lots, Inc.'s stock is valued at $45.28 at 13:22 EST, way under its 52-week high of $57.24 and way higher than its 52-week low of $10.13.